Page last updated: 2024-10-24

celiprolol and Aging

celiprolol has been researched along with Aging in 1 studies

Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.

Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.

Research Excerpts

ExcerptRelevanceReference
"Celiprolol hydrochloride is a cardioselective beta 1-adrenergic antagonist with partial agonist activity."6.38Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly. ( Lamon, KD, 1991)
"Celiprolol hydrochloride is a cardioselective beta 1-adrenergic antagonist with partial agonist activity."2.38Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly. ( Lamon, KD, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lamon, KD1

Reviews

1 review available for celiprolol and Aging

ArticleYear
Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly.
    Cardiovascular drugs and therapy, 1991, Volume: 4 Suppl 6

    Topics: Adrenergic beta-Antagonists; Aged; Aging; Celiprolol; Humans; Hypertension; Product Surveillance, Po

1991